Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.

Shintaro AkiyamaShadi HamdehDejan MicicAtsushi Sakuraba

Published in: Annals of the rheumatic diseases (2020)

Our meta-analysis demonstrated that patients with autoimmune diseases had an increased risk of COVID-19, primarily attributed to glucocorticoid use. b/tsDMARDs monotherapy was associated with a lower risk of severe COVID-19 suggesting its safety in the COVID-19 pandemic.

Keyphrases

coronavirus disease
sars cov
systematic review
respiratory syndrome coronavirus
risk factors
early onset
clinical trial
randomized controlled trial
open label
combination therapy
meta analyses
drug induced